The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
Abstract
BACKGROUND: Target of rapamycin inhibitors (TOR-I) have a novel mode of action but uncertain clinical role. We performed a systematic review of randomized trials where immunosuppressive regimens containing TOR-I were compared with other regimens as initial therapy for kidney transplant recipients. METHODS: Databases (inception, June 2005) and conference proceedings (1996-2005) were searched. Two independent reviewers assessed trials for eligibility and quality. Results at 1 year, are expressed as relative risk (RR), where values<1 favor TOR-I, or lower dose of TOR-I, and for continuous outcomes are expressed as weighted mean difference (WMD), both expressed with 95% confidence intervals (CI). RESULTS: Thirty-three trials (142 reports) were included (27 trials of sirolimus, 5 of everolimus, and 1 of head-to-head comparison). When TOR-I replaced calcineurin inhibitors (CNI) (8 trials with 750 participants), there was no difference in acute rejection (RR, 1.03; 95% CI, 0.74-1.44), but serum creatinine was lower (WMD, -18.31 micromol/L; 95% CI, -30.96 to -5.67) and bone marrow more suppressed (leukopenia: RR 2.02; 95% CI, 1.12-3.66; thrombocytopenia: RR, 6.97; 95% CI, 2.97-16.36; and anaemia: RR, 1.67; 95% CI, 1.27-2.20). When TOR-I replaced antimetabolites (11 trials with 3966 participants), acute rejection and cytomegalovirus infection (CMV) were reduced (RR, 0.84; 95% CI, 0.71-0.99; RR, 0.49; 95% CI, 0.37-0.65, respectively), but hypercholesterolemia was increased (RR, 1.65; 95% CI, 1.32-2.06). When low- was compared with high-dose TOR-I, with equal CNI dose (10 trials with 3,175 participants), rejection was increased (RR, 1.23; 95% CI, 1.06-1.43) but calculated glomerular filtration rate (GFR) higher (WMD, 4.27 mL/min; 95% CI, 1.12-7.41), and when lower-dose TOR-I and standard-dose CNI were compared with higher-dose TOR-I and reduced CNI, acute rejection was reduced (RR, 0.67; 95% CI, 0.52-0.88), but calculated GFR was also reduced (WMD, -9.46 mL/min; 95% CI, -12.16 to -6.76). There was no significant difference in mortality, graft loss, or malignancy risk for TOR-I in any comparison. CONCLUSIONS: TOR-I have been evaluated in four different primary immunosuppressive algorithms: as replacement for CNI and antimetabolites, in combination with CNI at low and high doses, and with a variable dose of CNI. Generally, surrogate endpoints for graft survival favor TOR-I (lower risk of acute rejection and higher GFR), and surrogate endpoints for patient outcomes are worsened by TOR-I (bone marrow suppression and lipid disturbance). Long-term hard-endpoint data from methodologically robust randomized trials are still required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Systematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
Hariharan, S., Johnson, C. P., Bresnahan, B. A., Taranto, S. E., McIntosh, M. J., & Stablein, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003023420901 · Cited by 1,835
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Stallone, G., Schena, A., Infante, B., Di Paolo, S., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042831 · Cited by 990
Kahan, B. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02480-6 · Cited by 913
Groth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6
Ruddle, F. H., & Meera Khan, P. (1976) · Cytogenetic and Genome Research · doi:10.1159/000130554 · Cited by 845
Post-transplant renal function in the first year predicts long-term kidney transplant survival
Hariharan, S., Mcbride, M. A., Cherikh, W. S., Tolleris, C. B., Bresnahan, B. A., & Johnson, C. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00424.x · Cited by 748
Kauffman, H. M., Cherikh, W. S., Cheng, Y., Hanto, D. W., & Kahan, B. D. (2005) · Transplantation · doi:10.1097/01.tp.0000184006.43152.8d · Cited by 621
MacDonald, A. S. (2001) · Transplantation · doi:10.1097/00007890-200101270-00019 · Cited by 621
Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R., & Sigal, N. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.251 · Cited by 603
Kreis, H., Cisterne, J.-M., Land, W., Wramner, L., Squifflet, J.-P., Abramowicz, D., Campistol, J. M., Morales, J.-M., Grinyo, J.-M., Mourad, G., et al. (2000) · Transplantation · doi:10.1097/00007890-200004150-00009 · Cited by 536
Rapamycin in transplantation: A review of the evidence
Saunders, R. N., Metcalfe, M. S., & Nicholson, M. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00460.x · Cited by 461
Flechner, S. M., Goldfarb, D., Modlin, C., Feng, J., Krishnamurthi, V., Mastroianni, B., Savas, K., Cook, D. J., & Novick, A. C. (2002) · Transplantation · doi:10.1097/00007890-200210270-00002 · Cited by 375
Dean, P. G., Lund, W. J., Larson, T. S., Prieto, M., Nyberg, S. L., Ishitani, M. B., Kremers, W. K., & Stegall, M. D. (2004) · Transplantation · doi:10.1097/01.tp.0000123082.31092.53 · Cited by 332
Mathew, T., Kreis, H., & Friend, P. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00188.x · Cited by 307
PREDICTING GLOMERULAR FILTRATION RATE AFTER KIDNEY TRANSPLANTATION
Nankivell, B. J., Gruenewald, S. M., Allen, R. D. M., & Chapman, J. R. (1995) · Transplantation · doi:10.1097/00007890-199506270-00007 · Cited by 292
Self-citationFlechner, S. M., Kurian, S. M., Solez, K., Cook, D. J., Burke, J. T., Rollin, H., Hammond, J. A., Whisenant, T., Lanigan, C. M., Head, S. R., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00627.x · Cited by 281
Kahan, B. D., Julian, B. A., Pescovitz, M. D., Vanrenterghem, Y., & Neylan, J. (1999) · Transplantation · doi:10.1097/00007890-199911270-00016 · Cited by 279
Vitko, S., Tedesco, H., Eris, J., Pascual, J., Whelchel, J., Magee, J. C., Campbell, S., Civati, G., Bourbigot, B., Filho, G. A., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00389.x · Cited by 254
SDZ RAD, A NEW RAPAMYCIN DERIVATIVE: Synergism with Cyclosporine
Schuurman, H.-J., Cottens, S., Fuchs, S., Joergensen, J., Meerloo, T., Sedrani, R., Tanner, M., Zenke, G., & Schuler, W. (1997) · Transplantation · doi:10.1097/00007890-199707150-00007 · Cited by 248
Payment for Living Donor (Vendor) Kidneys: A Cost-Effectiveness Analysis
Matas, A. J., & Schnitzler, M. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00290.x · Cited by 234
Lorber, M. I., Mulgaonkar, S., Butt, K. M. H., Elkhammas, E., Mendez, R., Rajagopalan, P. R., Kahan, B., Sollinger, H., Li, Y., Cretin, N., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000164352.65613.24 · Cited by 231
RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1
Kahan, B. D., & Camardo, J. S. (2001) · Transplantation · doi:10.1097/00007890-200110150-00001 · Cited by 225
Oberbauer, R., Segoloni, G., Campistol, J. M., Kreis, H., Mota, A., Lawen, J., Russ, G., Grinyo, J. M., Stallone, G., Hartmann, A., et al. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00052.x · Cited by 225
Self-citationThe aging kidney: insights from experimental studies.
Baylis, C., & Corman, B. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v94699 · Cited by 220
Vítko, Š., Margreiter, R., Weimar, W., Dantal, J., Kuypers, D., Winkler, M., Øyen, O., Viljoen, H. G., Filiptsev, P., Sadek, S., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01063.x · Cited by 216
Woodroffe, R., Yao, G., Meads, C., Bayliss, S., Ready, A., Raftery, J., & Taylor, R. (2005) · Health Technology Assessment · doi:10.3310/hta9210 · Cited by 195
Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients
Morales, J. M., Wramner, L., Kreis, H., Durand, D., Campistol, J. M., Andres, A., Arenas, J., Nègre, E., Burke, J. T., & Groth, C. G. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20507.x · Cited by 188
Gonwa, T., Mendez, R., Yang, H. C., Weinstein, S., Jensik, S., & Steinberg, S. (2003) · Transplantation · doi:10.1097/01.tp.0000062837.99400.60 · Cited by 187
Gonwa, T. A., Hricik, D. E., Brinker, K., Grinyo, J. M., & Schena, F. P. (2002) · Transplantation · doi:10.1097/00007890-200212150-00013 · Cited by 165
Hong, J. C., & Kahan, B. D. (2000) · Transplantation · doi:10.1097/00007890-200005270-00019 · Cited by 162
Ciancio, G., Burke, G. W., Gaynor, J. J., Mattiazzi, A., Roth, D., Kupin, W., Nicolas, M., Ruiz, P., Rosen, A., & Miller, J. (2004) · Transplantation · doi:10.1097/01.tp.0000101495.22734.07 · Cited by 160
Vítko, Š., Margreiter, R., Weimar, W., Dantal, J., Viljoen, H. G., Li, Y., Jappe, A., & Cretin, N. (2004) · Transplantation · doi:10.1097/01.tp.0000141094.34903.54 · Cited by 160
Kovařík, J. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.112969 · Cited by 153
Mendez, R., Gonwa, T. A., Yang, H. C., Weinstein, S., Jensik, S. C., & Steinberg, S. (2005) · Transplantation · doi:10.1097/01.tp.0000167757.63922.42 · Cited by 144
Kovarik, J. M., Kaplan, B. E., Junior, H. T. S., Kahan, B. D., Dantal, J., Vitko, S., Boger, R. S., & Rordorf, C. M. (2002) · Transplantation · doi:10.1097/00007890-200203270-00016 · Cited by 138
Kumar, D., Tellier, R., Draker, R., Levy, G. A., & Humar, A. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00197.x · Cited by 138
Ciancio, G., Burke, G. W., Gaynor, J. J., Mattiazzi, A. D., Roth, D., Kupin, W. L., Nicolas, M., Ruiz, P., Rosen, A. L., & Miller, J. (2004) · Transplantation · doi:10.1097/01.tp.0000101290.20629.dc · Cited by 126
Kovarik, J. M. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.118022 · Cited by 124
Mulay, A. V., Hussain, N., Fergusson, D. A., & Knoll, G. A. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00931.x · Cited by 115
Long-Term Deterioration of Kidney Allograft Function
Kasiske, B. L., Gaston, R. S., Gourishankar, S., Halloran, P. F., Matas, A. J., Jeffery, J., & Rush, D. N. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00853.x · Cited by 115
Kandaswamy, R., Melancon, J. K., Dunn, T. B., Tan, M., Casingal, V. P., Humar, A., Payne, W. D., Gruessner, R. W. G., Dunn, D. L., Najarian, J. S., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00885.x · Cited by 105
Kahan, B. D., Kaplan, B. E., Lorber, M. I., Winkler, M., Cambon, N., & Boger, R. S. (2001) · Transplantation · doi:10.1097/00007890-200105270-00008 · Cited by 104
Kovarik, J. M., Junior, H. T. S., Pascual, J., Civati, G., Bizot, M., Geissler, J. F., & Schmidli, H. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200410000-00007 · Cited by 100
Stepkowski, S. M., TIAN, L., Napoli, K. L., Ghobrial, R. M., Wang, M., Chou, T., & Kahan, B. D. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-984.x · Cited by 96
Blum, C. B. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20610.x · Cited by 92
SDZ-RAD PREVENTS MANIFESTATION OF CHRONIC REJECTION IN RAT RENAL ALLOGRAFTS
Viklick�, O. E., Zou, H., Müller, V., Lacha, J., Szab�, A., & Heemann, U. W. (2000) · Transplantation · doi:10.1097/00007890-200002270-00006 · Cited by 82
Kahan, B. D. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00353-1 · Cited by 75
Gallagher, M., Hall, B. M., Craig, J. C., Berry, G., TILLER, D. J., & Eris, J. (2004) · Transplantation · doi:10.1097/01.tp.0000144181.47045.fe · Cited by 74
Self-citationKovarik, J. M., Kaplan, B. E., Junior, H. T. S., Kahan, B. D., Dantal, J., McMahon, L. M., Berthier, S., Hsu, C.-H., & Rordorf, C. M. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00107.x · Cited by 69
van Hooff, J. P., Squifflet, J., Włodarczyk, Z., Vanrenterghem, Y. F. C., & Pączek, L. (2003) · Transplantation · doi:10.1097/01.tp.0000071301.86299.75 · Cited by 67
Median effect analysis of efficacy versus adverse effects of immunosuppressants
Kahan, B. D., & Kramer, W. G. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116309 · Cited by 56
Frontal Impairment in Subcortical Ischemic Vascular Dementia in Comparison to Alzheimer’s Disease
Cannatà, A. P., Alberoni, M., Franceschi, M., & Mariani, C. B. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048641 · Cited by 54
Krämer, B. K., Neumayer, H. H., Stahl, R. K., et al. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2004.09.026 · Cited by 46
Hypolite, I. O., Bucci, J. R., Hshieh, P., Cruess, D. F., Agodoa, L. Y. C., Yuan, C. M., Taylor, A. J., & Abbott, K. C. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20313.x · Cited by 45
Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients
Russ, G. R., Campbell, S. B., Chadban, S., Eris, J., O’Connell, P. R., Pussell, B. A., & Walker, R. G. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00210-0 · Cited by 38
Legendre, C., Campistol, J. M., Squifflet, J.-P., & Burke, J. T. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00241-0 · Cited by 38
Kidney transplantation without calcineurin inhibitors using sirolimus
Stegall, M. D., Larson, T. S., Prieto, M., Gloor, J. M., Textor, S. C., Nyberg, S. L., Sterioff, S., Ishitani, M., Griffin, M. D., Kremers, W. K., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00226-4 · Cited by 34
Charpentier, B., Groth, C. G., Bäckman, L., Morales, J. M., Calne, R. Y., Kreis, H., Lang, P., Touraine, J. L., Claesson, K., Campistol, J. M., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00213-6 · Cited by 29
Junior, H. T. S., Felipe, C. R., Machado, P. G. P., Garcia, R., Motegi, S., Hosaka, B., Hanzawa, N. M., Park, S. I., Casarini, D. E., de Lima, V. C. C., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00232-x · Cited by 8
Cited by
Costanzo, M. R., Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., Fedson, S., Fisher, P., Gonzales-Stawinski, G., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,653
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Antiviral Drug Resistance of Human Cytomegalovirus
Lurain, N. S., & Chou, S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-10 · Cited by 596
PEComas: the past, the present and the future
Martignoni, G., Pea, M., Reghellin, D., Zamboni, G., & Bonetti, F. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0509-1 · Cited by 551
Metadata
- Authors
- Webster, A. C., Lee, V. W. S., Chapman, J. R., & Craig, J. C.
- Venue
- Transplantation
- Published
- 2006-05-15
- Volume
- 81
- Issue
- 9
- Pages
- 1234-1248
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2046576895
- Cited by
- 335
- References
- 63
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.